Amanta Healthcare, a pharmaceutical manufacturer, is scheduled to inaugurate its ₹126 crore IPO on September 1, through an offer of 1 crore fresher equity shares. The public offering plans to have more funds allocated for facility expansion and to strengthen the company’s manufacturing capacity.
Amanta Healthcare Limited, a pharmaceutical company from Ahmedabad, Gujarat, offers sterile liquid products and medical devices as its specialty. The company was established in 1994 and has been successful in packaging technology of the future like Aseptic Blow-Fill-Sepal (ABFS) and Injection Stretch Blow Moulding (ISBM). The company has been growing steadily and is well-known as it can provide healthcare products to both the Indian and foreign markets.
The company’s new Initial Public Offering (IPO) is a landmark moment in its 30-year history and signifies a step closer to its goal of increasing production and extending the range of products available in the healthcare sector.
Amanta Healthcare IPO: Size and Structure
Amanta Healthcare’s IPO will open for subscription on September 1, 2025 and will be available till September 3, 2025.
The ₹126 crore mainboard initial public offering (IPO) is entirely a fresh 1 crore shares equity release. There is no offer-for-sale (OFS) component, which means that the company will directly use the money raised for cash flow rather than promoter holdings be diluted.
This design clearly indicates that the company is not looking for the money but instead wants to focus on growth and development, hence, providing the investors an opportunity to access the next phase of expansion in the company.
Amanta Healthcare IPO: Price Band and Lot Size
The IPO price range has been set between ₹120 and ₹126 per share.
For retail investors:
- Minimum application: 119 shares
- Investment value: At the upper price band, ₹14,994
For non-institutional investors (NIIs):
- Small NII: About Rs 2.1 lakh minimum investment
- Big NII: About Rs 10 lakh minimum investment
The allocation makes it possible for as many people as possible to take part in it while keeping the entry point simple for retail investors, which is a crucial point for investor relations.
Also Read: Amanta Healthcare IPO Opens: Gujarat Pharma Firm Targets ₹126 Crore Raise
Amanta Healthcare IPO: Important Dates
Investors should remember the following key dates in the IPO schedule:
- IPO Opens: September 1, 2025
- IPO Closes: September 3, 2025
- Basis of Allotment: September 4, 2025
The dual listing on the two big exchanges is beneficial as it provides wider accessibility to liquidity and better visibility for both institutional and retail investors.
Use of Proceeds: Funding Expansion
As per the information contained in the company’s Red Herring Prospectus (RHP), the money raised through the IPO is expected to be mainly utilized for the expansion of the Hariyala unit in Kheda, Gujarat.
- Almost 70% of the money will be directed towards the construction of a new building and the purchase of equipment for the SteriPort manufacturing line.
- The rest of the 30% will be used to the SVP line to increase the production capacity of the sterile liquid product portfolio.
- A smaller part of the company’s general corporate purposes will be used to increase its financial flexibility.
This facility expansion plans to back Amanta’s strategy of catering the increasing need for the pharmaceutical market in the country and abroad.
Amanta Healthcare IPO: Valuation Metrics
If the issue is priced at the upper end of the band, i.e., ₹126, a post-money market cap of around ₹489 crore is envisaged for the company.
The corresponding Price-to-Earnings (P/E) ratio is 46.6x, indicating a fair amount of trust in the company’s growth potential by the investors. When compared to listed peers in the pharmaceutical sector, the valuation trend shows that it sits at the middle of the range with a slight premium, justified by Amanta’s niche product portfolio and the company’s growth prospects driven by the expansion.
Amanta Healthcare IPO: Business Fundamentals
Amanta Healthcare’s competitive advantages are as follows:
- Targeted production: the production of sterile liquids and parenterals is the main focus; these are products that require sophisticated technology and are subject to regulatory procedures.
- Highly reliable tech: the use of ABFS and ISBM technologies allows for the utmost quality of packaging, which is fundamental for guaranteeing the integrity of the pharmaceutical products.
- Varied Portfolio: the company’s activities cover not only drugs but also medical devices, thus the firm is less exposed to the risk of the pharma vertical.
- Business Expansion Paths: there are plans for an increase in capacity and turnover due to the new projects in Gujarat plants.
These essentials fit the trend of the long-term drivers of sectoral growth such as the rising demand for health services, increased hospital infrastructure, and India’s position as a global pharmaceutical hub.
FAQ’s
Q1. What is the size of Amanta Healthcare IPO?
1 crore fresh equity shares making up the IPO size is ₹126 crore.
Q2. When will the Amanta Healthcare IPO open and close?
The closing date for the subscription is September 3, 2025, while the opening date is September 1, 2025.
Q3. Where will Amanta Healthcare shares be listed?
The shares of the company shall be listed on the NSE and BSE from September 9, 2025.
READ MORE ON